Gripalgin

Gripalgin is an over‑the‑counter oral medication that combines chlorphenamine maleate, phenylephrine bitartrate and paracetamol. It is formulated for the relief of common cold and flu symptoms and is marketed in the European Union. The product leverages an antihistamine, a nasal decongestant and an analgesic/antipyretic in a single dose, providing a multi‑symptom approach without prescription. It is intended for adult use and may be taken as directed on the package.

Gripalgin is indicated for the symptomatic treatment of upper respiratory infections such as the common cold and influenza.

- Relief of nasal congestion caused by swollen nasal passages. - Reduction of headache, fever, and sore throat associated with viral infections. - Alleviation of watery eyes, runny nose, and sneezing due to allergic components of cold. - Temporary easing of body aches and mild pain that accompany flu-like illness. - Support for improved comfort during rest and daily activities when experiencing cold symptoms. - Assistance in maintaining normal sleep patterns disrupted by congestion and discomfort.

The combination of chlorphenamine, phenylephrine and paracetamol may produce a range of adverse effects. Most are mild, dose‑related, and resolve without medical intervention, but patients should be aware of the typical profile.

Common: - Drowsiness, mild sedation, or feeling of fatigue. - Dryness of the mouth, throat, or nasal mucosa. - Nausea, mild stomach upset, or transient loss of appetite. - Light‑headedness or a brief increase in heart rate. - Mild headache or dizziness that improves with rest.

Serious: - Severe allergic reaction such as rash, itching, swelling of the face or throat, or difficulty breathing (anaphylaxis). - Marked increase in blood pressure, chest pain, or signs of cardiovascular strain. - Liver dysfunction indicated by jaundice, dark urine, or persistent abdominal pain.

When using Gripalgin, certain precautions should be observed to minimize risk and ensure safe use.

- Do not exceed the recommended dose; overdose increases risk of liver injury from paracetamol. - Use caution if you have hypertension, heart disease, diabetes, or thyroid disorders, as phenylephrine may raise blood pressure. - Avoid if you are hypersensitive to any ingredient. - Consult a healthcare professional before use during pregnancy, breastfeeding, or in children. - Limit alcohol while taking this medication, as it may increase liver toxicity. - Chlorphenamine can cause drowsiness; avoid driving or operating machinery until you know how you react.

Gripalgin may interact with other medicines; recognizing potential interactions helps maintain safety.

Avoid: - Concurrent use with other products containing paracetamol or acetaminophen, which can lead to excessive dosing and liver damage. - Combining with monoamine oxidase inhibitors (MAOIs) or other sympathomimetic agents, which may cause excessive cardiovascular stimulation.

Use with caution: - Other antihistamines or sedatives, as additive drowsiness may occur. - Anticoagulants or antiplatelet drugs, because paracetamol can modestly affect bleeding risk. - Certain antidepressants (e.g., SSRIs) or tramadol, which may increase the risk of serotonin syndrome when combined with phenylephrine. - Patients taking diuretics should monitor electrolyte balance, as phenylephrine may affect potassium levels.